Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenues    
Revenues $ 18,326,801 $ 27,813,137
Operating expenses:    
Cost of product sales 7,478,262 635,648
Research and development 5,786,635 4,372,578
Acquired in-process research and development 18,723,952 0
General and administrative 10,676,881 7,941,584
Sales and marketing 8,522,461 569,825
Amortization expense 4,532,448 403,520
Impairment of intangible assets 1,861,562 0
Change in fair value of contingent consideration 58,366 0
Total operating expenses 57,640,567 13,923,155
(Loss) income from operations (39,313,766) 13,889,982
Other (expense) income:    
Change in fair value of warrant liability and unit purchase option liability 25,010 (29,624)
Other income, net 13,657 0
Interest expense, net (811,621) (24,016)
Total other expense, net (772,954) (53,640)
Net (loss) income before taxes (40,086,720) 13,836,342
Income tax (benefit) expense (33,910) 1,966,519
Net (loss) income after taxes (40,052,810) 11,869,823
Net (loss) income attributable to common shareholders $ (41,710,193) $ 7,772,084
Net income (loss) per share of common stock, basic (in dollars per share) $ (1.20) $ 0.42
Net income (loss) per share of common stock, diluted (in dollars per share) $ (1.20) $ 0.42
Weighted average shares of common stock outstanding, basic (in shares) 34,773,613 18,410,005
Weighted average number of shares of common stock outstanding, diluted (in shares) 34,773,613 18,754,799
Product revenue, net    
Revenues    
Revenues $ 17,870,745 $ 1,910,403
Sales force revenue    
Revenues    
Revenues 456,056 278,165
License and other revenue    
Revenues    
Revenues 0 25,000,000
Grant revenue    
Revenues    
Revenues $ 0 $ 624,569